132 related articles for article (PubMed ID: 11280785)
1. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
Boulay A; Masson R; Chenard MP; El Fahime M; Cassard L; Bellocq JP; Sautès-Fridman C; Basset P; Rio MC
Cancer Res; 2001 Mar; 61(5):2189-93. PubMed ID: 11280785
[TBL] [Abstract][Full Text] [Related]
2. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
[TBL] [Abstract][Full Text] [Related]
3. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC
Cancer Res; 2003 Sep; 63(18):5844-9. PubMed ID: 14522908
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin-3 expression promotes tumor take in nude mice.
Nöel AC; Lefebvre O; Maquoi E; VanHoorde L; Chenard MP; Mareel M; Foidart JM; Basset P; Rio MC
J Clin Invest; 1996 Apr; 97(8):1924-30. PubMed ID: 8621777
[TBL] [Abstract][Full Text] [Related]
5. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Rio MC
Biochimie; 2005; 87(3-4):299-306. PubMed ID: 15781316
[TBL] [Abstract][Full Text] [Related]
6. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM
Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal regulation of collagenases-3, -4, and stromelysin -3 implicates distinct functions in apoptosis and tissue remodeling during frog metamorphosis.
Damjanovski S; Ishizuya-Oka A; Shi YB
Cell Res; 1999 Jun; 9(2):91-105. PubMed ID: 10418731
[TBL] [Abstract][Full Text] [Related]
8. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
Damjanovski S; Amano T; Li Q; Pei D; Shi YB
Dev Dyn; 2001 May; 221(1):37-47. PubMed ID: 11357192
[TBL] [Abstract][Full Text] [Related]
10. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.
Houghton AM; Grisolano JL; Baumann ML; Kobayashi DK; Hautamaki RD; Nehring LC; Cornelius LA; Shapiro SD
Cancer Res; 2006 Jun; 66(12):6149-55. PubMed ID: 16778188
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
12. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
[TBL] [Abstract][Full Text] [Related]
13. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
Amano T; Kwak O; Fu L; Marshak A; Shi YB
Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
[TBL] [Abstract][Full Text] [Related]
14. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
15. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Kannan R; Ruff M; Kochins JG; Manly SP; Stoll I; El Fahime M; Noël A; Foidart JM; Rio MC; Dive V; Basset P
Protein Expr Purif; 1999 Jun; 16(1):76-83. PubMed ID: 10336863
[TBL] [Abstract][Full Text] [Related]
16. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
McCawley LJ; Crawford HC; King LE; Mudgett J; Matrisian LM
Cancer Res; 2004 Oct; 64(19):6965-72. PubMed ID: 15466188
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
18. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
19. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
20. Expression of stromelysin-3 (matrix metalloproteinase-11) in macrophages of murine thymus following thymocyte apoptosis.
Odaka C; Izumiyama S
Cell Immunol; 2005 May; 235(1):21-8. PubMed ID: 16165118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
